BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/12/2023 7:20:47 AM | Browse: 639 | Download: 1563
 |
Received |
|
2022-10-09 09:42 |
|
Peer-Review Started |
|
2022-10-09 09:46 |
|
First Decision by Editorial Office Director |
|
2022-12-13 03:24 |
|
Return for Revision |
|
2022-12-13 03:24 |
|
Revised |
|
2022-12-21 08:30 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-12-30 03:17 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-01-03 00:47 |
|
Articles in Press |
|
2023-01-03 00:47 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-01-03 07:54 |
|
Publish the Manuscript Online |
|
2023-01-12 07:20 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Case Report |
| Article Title |
Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Guo-Chun Ou, Wen Luo, Wei-Shan Zhang, Shu-Hong Wang, Jie ZHao, Hong-Mei Zhao and Rong Qiu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Science and Technology Research Project of Sichuan Provincial Administration of Traditional Chinese Medicine |
2021MS164 |
| Scientific research project of Sichuan Medical Association |
S21012 |
|
| Corresponding Author |
Rong Qiu, PhD, Doctor, Doctor, Department of Respiratory and Critical Care Medicine, Suining Central Hospital, No. 27 Dongping North Road, Hedong New District, Chuanshan District, Suining 629000, Sichuan Province, China. snszxyyqr@126.com |
| Key Words |
Gefitinib; Epidermal growth factor receptor; Lung cancer; Bronchorrhea; Lung invasive mucinous adenocarcinoma; Case report |
| Core Tip |
Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma. |
| Publish Date |
2023-01-12 07:20 |
| Citation |
Ou GC, Luo W, Zhang WS, Wang SH, Zhao J, Zhao HM, Qiu R. Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report. World J Clin Cases 2023; 11(2): 441-448
|
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i2/441.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i2.441 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
